Vitrolife AB (VITR)

Currency in SEK
106.80
-1.60(-1.48%)
Closed·
VITR is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
103.30109.50
52 wk Range
84.60160.70
Key Statistics
Prev. Close
108.4
Open
107.9
Day's Range
103.3-109.5
52 wk Range
84.6-160.7
Volume
285.98K
Average Volume (3m)
242.67K
1-Year Change
-28.4662%
Book Value / Share
59.58
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
VITR Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
162.75
Upside
+52.39%
Members' Sentiments
Bearish
Bullish
ProTips
Net income is expected to grow this year

Vitrolife AB News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Sell

Analyst Ratings

3 Buy
1 Hold
0 Sell
Ratings:
4 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 162.75
(+52.39% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Vitrolife AB Earnings Call Summary for Q3/2025

  • Vitrolife reported 5% organic sales growth to SEK 835 million in Q3 2025, with gross margin improving to 58.9% and EBITDA reaching SEK 253 million
  • Stock rose 0.48% pre-market; company trades below Fair Value per InvestingPro analysis, suggesting potential upside
  • Strong performance in Americas and EMEA offset challenges in APAC; focus on innovation and IT investments bolstered competitive edge
  • Management cautiously optimistic about market recovery, particularly in U.S. fertility sector; monitoring impact of U.S. presidential IVF announcement
  • Analysts maintain Buy rating; company faces risks in APAC sales, macroeconomic pressures, and potential regulatory changes
Last Updated: 23/10/2025, 10:26
Read Full Transcript

Earnings

Latest Release
23/04/2026
EPS / Forecast
0.74 / 0.77
Revenue / Forecast
807M / 810.01M
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -37.01%
Dividend Yield
1.02%
Industry Median 1.92%
Annualised payout
1.10
Paid annually
5-Years Growth
+6.58%
Growth Streak

Compare VITR to Peers and Sector

Metrics to compare
VITR
Peers
Sector
Relationship
P/E Ratio
−2.9x22.1x−0.5x
PEG Ratio
0.000.750.00
Price/Book
1.8x3.2x2.6x
Price / LTM Sales
4.3x3.7x3.1x
Upside (Analyst Target)
40.7%62.1%53.0%
Fair Value Upside
Unlock9.0%6.3%Unlock

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. The company was incorporated in 1989 and is based in Gothenburg, Sweden.

Employees
1126
Market
Sweden

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
24.12M17.81%2.61B
Other Institutional Investors
81.76M60.38%8.86B
Public Companies & Retail Investors
29.54M21.81%3.20B
Total
135.42M100.00%14.68B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
William Demant Invest A/S29.65%40,154,5564,352,754
Bure Equity AB (publ)15.88%21,510,2572,331,712

People Also Watch

150.90
ALIFb
+0.87%
256.80
BONEX
-1.53%
340.40
ADDTb
+2.35%
276.80
SECTb
+0.87%
525.50
CAMX
-0.94%

FAQ

What Is the Vitrolife (Stockholm: VITR) Share Price Today?

The Vitrolife stock price today is 106.80 SEK.

What Stock Exchange Does Vitrolife (VITR) Trade On?

Vitrolife is listed and trades on the Stockholm Stock Exchange.

What Is the Ticker (Stock Symbol) for Vitrolife?

The stock symbol (also called a 'ticker') for Vitrolife is "VITR."

Does Vitrolife Pay Dividends? What’s The Current VITR Dividend Yield?

Yes, VITR Pays Dividends to its Shareholders. The current Vitrolife dividend yield is 1.02%.

What Is the Current Vitrolife Market Capitalisation?

As of today, Vitrolife (Stockholm: VITR) market cap is 14.49B SEK.

What Is Vitrolife's (VITR) Earnings Per Share (TTM)?

The Vitrolife EPS is currently -37.01 (Trailing Twelve Months).

When Is the Next Vitrolife Earnings Date?

Vitrolife's next earnings report will be released on 16/07/2026.

Is VITR a Buy or Sell From a Technical Analyst Perspective?

Based on today's Vitrolife moving averages and other technical indicators, the daily buy/sell signal for VITR stock is Neutral.

How Many Times Has Vitrolife Stock Split?

Vitrolife has split 1 times. (See the VITR stock split history page for full effective split date and price information.)

How Many Employees Does Vitrolife Have?

Vitrolife has 1126 employees, based on their latest Companies House report.

What is the current trading status of Vitrolife (Stockholm: VITR)?

As of 23/05/2026, Vitrolife (VITR) is trading at a share price of 106.80 SEK, with a previous close of 108.40 SEK. The stock has fluctuated within a day range of 103.30 SEK to 109.50 SEK, while its 52-week range spans from 84.60 SEK to 160.70 SEK.

What Is Vitrolife (VITR) Price Target According to Analysts?

The average 12-month price target for Vitrolife is 162.75 SEK, with a high estimate of 215 SEK and a low estimate of 131 SEK. 3 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +52.39% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.